U.S.-based health and wellness retailing company GNC Holdings Inc. has completed with $150 million in an investment round.
The investment, which came from Chinese drugmaker Harbin Pharmaceutical Group Co. Ltd., is part of its previously announced $300 million strategic investment.
As a result of the infusion, GNC Holdings also announced the formation of China second, a retail-focused joint venture with Hayao.
The second JV is expected to be closed in the second or third quarter of 2019, subject to certain routine regulatory and legal requirements.